evolocumab,alirocumab, bempedoic acid
regeneron,amgen,esperion
['alirocumab', 'evolocumab']
 you have to take into account baseline ldlc levels. in bempedoic acid trial 3.6 mm/l, in evolocumab 2.4, alirocumab 2.0, ezetimib 1.8. the last 3 drugs would probably do better with higher baseline ldlc.